Skip to main content

Advertisement

Log in

Integration pattern of HIV-1 based lentiviral vector carrying recombinant coagulation factor VIII in Sk-Hep and 293T cells

  • Original Research Paper
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

293T and Sk-Hep-1 cells were transduced with a replication-defective self-inactivating HIV-1 derived vector carrying FVIII cDNA. The genomic DNA was sequenced to reveal LTR/human genome junctions and integration sites. One hundred and thirty-two sequences matched human sequences, with an identity of at least 98%. The integration sites in 293T-FVIIIDB and in Sk-Hep-FVIIIDB cells were preferentially located in gene regions. The integrations in both cell lines were distant from the CpG islands and from the transcription start sites. A comparison between the two cell lines showed that the lentiviral-transduced DNA had the same preferred regions in the two different cell lines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Antequera F, Bird A (1999) CpG islands as genomic footprints of promoters that are associated with replication origins. Curr Biol 9:R661–R667

    Article  CAS  PubMed  Google Scholar 

  • Beard BC, Dickerson D, Beebe K, Gooch C, Fletcher J, Okbinoglu T, Miller DG, Jacobs MA, Kaul R, Kiem HP, Trobridge GD (2007) Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells. Mol Ther 15:1356–1365

    Article  CAS  PubMed  Google Scholar 

  • Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288:669–672

    Article  CAS  PubMed  Google Scholar 

  • Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, Fischer A (2003a) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348:255–256

    Article  PubMed  Google Scholar 

  • Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N et al (2003b) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415–419

    Article  CAS  PubMed  Google Scholar 

  • Hacker CV, Vink CA, Wardell TW, Lee S, Treasure P, Kingsman SM, Mitrophanous KA, Miskin JE (2006) The integration profile of EIAV-based vectors. Mol Ther 14:536–545

    Article  CAS  PubMed  Google Scholar 

  • Kim S, Kim N, Dong B, Boren D, Lee SA, Das Gupta J, Gaughan C, Klein EA, Lee C, Silverman RH, Chow SA (2008) Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J Virol 82:9964–9977

    Article  CAS  PubMed  Google Scholar 

  • Kustikova O, Fehse B, Modlich U, Yang M, Dullmann J, Kamino K, von Neuhoff N, Schlegelberger B, Li Z, Baum C (2005) Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308:1171–1174

    Article  CAS  PubMed  Google Scholar 

  • Laufs S, Guenechea G, Gonzalez-Murillo A, Zsuzsanna Nagy K, Luz Lozano M, del Val C, Jonnakuty S, Hotz-Wagenblatt A, Jens Zeller W, Bueren JA, Fruehauf S (2006) Lentiviral vector integration sites in human NOD/SCID repopulating cells. J Gene Med 8:1197–1207

    Article  CAS  PubMed  Google Scholar 

  • Lavie L, Maldener E, Brouha B, Meese EU, Mayer J (2004) The human L1 promoter: variable transcription initiation sites and a major impact of upstream flanking sequence on promoter activity. Genome Res 14:2253–2260

    Article  CAS  PubMed  Google Scholar 

  • Lewinski MK, Yamashita M, Emerman M, Ciuffi A, Marshall H, Crawford G, Collins F, Shinn P, Leipzig J, Hannenhalli S, Berry CC, Ecker JR, Bushman FD (2006) Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog 2:e60

    Article  PubMed  Google Scholar 

  • Li Z, Dullmann J, Schiedlmeier B, Schmidt M, von Kalle C, Meyer J, Forster M, Stocking C, Wahlers A, Frank O, Ostertag W, Kuhlcke K, Eckert HG, Fehse B, Baum C (2002) Murine leukemia induced by retroviral gene marking. Science 296:497

    Article  CAS  PubMed  Google Scholar 

  • Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC, Ecker JR, Bushman FD (2004) Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2:E234

    Article  PubMed  Google Scholar 

  • Montini E, Cesana D, Schmidt M, Sanvito F, Ponzoni M, Bartholomae C, Sergi Sergi L, Benedicenti F, Ambrosi A, Di Serio C, Doglioni C, von Kalle C, Naldini L (2006) Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 24:687–696

    Article  CAS  PubMed  Google Scholar 

  • Picanco V, Heinz S, Bott D, Behrmann M, Covas DT, Seifried E, Tonn T (2007) Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter. Cytotherapy 9:785–794

    Article  CAS  PubMed  Google Scholar 

  • Picanço-Castro V, Fontes AM, Russo-Carbolante EMS, Covas DT (2008) Lentiviral-mediated gene transfer—a patent review. Exp Opin Therap Patents 18(5):525–539

    Article  Google Scholar 

  • Rohdewohld H, Weiher H, Reik W, Jaenisch R, Breindl M (1987) Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites. J Virol 61:336–343

    CAS  PubMed  Google Scholar 

  • Tonn T, Herder C, Becker S, Seifried E, Grez M (2002) Generation and characterization of human hematopoietic cell lines expressing factor VIII. J Hematother Stem Cell Res 11:695–704

    Article  CAS  PubMed  Google Scholar 

  • Venter JC, Adams MD, Meyers E, Li PW, Mural RJ et al. (2001) The Sequence of the Human Genome. Science 1304–1351

  • Wu X, Li Y, Crise B, Burgess SM (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749–1751

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Adriana Aparecida Marques who helped with the sequencing. This work was supported by CNPq (Conselho Nacional de Desenvolvimento Tecnológico) and FAPESP (Fundação de Amparo a Pesquisa do Estado de São Paulo).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elisa Maria de Sousa Russo-Carbolante.

Additional information

Purpose of work We have examined lentiviral integration site selection in hepatocyte and kidney cell lines to see whether there are determinants of integration tendency other than the structure and biological characteristics of lentiviruses.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 18 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Sousa Russo-Carbolante, E.M., Picanço-Castro, V., Alves, D.C.C. et al. Integration pattern of HIV-1 based lentiviral vector carrying recombinant coagulation factor VIII in Sk-Hep and 293T cells. Biotechnol Lett 33, 23–31 (2011). https://doi.org/10.1007/s10529-010-0387-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-010-0387-5

Keywords

Navigation